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ABSTRACT Postnatal enlargement of the mammalian intestine comprises cylindrical and lu-
minal growth, associated with crypt fission and crypt/villus hyperplasia, respectively, which 
subsequently predominate before and after weaning. The bipartite adhesion G protein–cou-
pled receptor CD97 shows an expression gradient along the crypt–villus axis in the normal 
human intestine. We here report that transgenic mice overexpressing CD97 in intestinal epi-
thelial cells develop an upper megaintestine. Intestinal enlargement involves an increase in 
length and diameter but does not affect microscopic morphology, as typical for cylindrical 
growth. The megaintestine is acquired after birth and before weaning, independent of the 
genotype of the mother, excluding altered availability of milk constituents as driving factor. 
CD97 overexpression does not regulate intestinal growth factors, stem cell markers, and Wnt 
signaling, which contribute to epithelial differentiation and renewal, nor does it affect suck-
ling-to-weaning transition. Consistent with augmented cylindrical growth, suckling but not 
adult transgenic mice show enlarged crypts and thus more crypt fissions caused by a transient 
increase of the crypt transit-amplifying zone. Intestinal enlargement by CD97 requires its 
seven-span transmembrane/cytoplasmic C-terminal fragment but not the N-terminal frag-
ment binding partner CD55. In summary, ectopic expression of CD97 in intestinal epithelial 
cells provides a unique model for intestinal cylindrical growth occurring in breast-fed infants.
INTRODUCTION
The generation of the mature mammalian intestinal tract entails 
dramatic morphological changes, yet the mechanisms that underlie 
intestinal growth after birth are largely obscure (Cummins and 
Thompson, 2002). Postnatal expansion of the epithelial surface of 
the small intestine occurs by two growth patterns known as cylindri-
cal and luminal growth, respectively (Cummins and Thompson, 
2002). In human infants, during milk feeding, cylindrical growth, 
comprising a gain in length and diameter without obvious micro-
scopic morphological changes, predominates and peaks simultane-
ously with crypt fission, that is, the longitudinal division of crypts 
during the first year (Cummins et al., 2008). Thereafter crypt fission 
declines rapidly yet remains present at low level during adult life 
(Cummins and Thompson, 2002; Cummins et al., 2008). After wean-
ing, luminal mucosal growth, characterized by crypt hyperplasia and 
a gain in submucosal folds and villi, becomes the dominant growth 
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newborn and infant mice, we hardly found expression of CD97 in 
intestinal epithelial cells using immunohistology (data not shown). 
Of note, we found that a small number of crypt cells stain blue in a 
CD97 LacZ knock-in mouse model (Becker et al., 2010). Thus the 
available tools provide no conclusive answer to the question of 
whether murine intestinal epithelial cells express CD97. Technically, 
this is not trivial, because other cell types present in the intestine, 
such as smooth muscle cells, fibroblasts, and leucocytes, are CD97 
positive.
We therefore applied a transgenic mouse model to investigate 
the significance of CD97 expression in epithelial cells (Becker et al., 
2010).
Overexpression of CD97 results in a megaintestine, with 
increased length and diameter of the upper small bowel
The villin promoter drives gene expression in immature and differ-
entiated intestinal epithelial cells (Maunoury et al., 1988). We previ-
ously generated three lines of Tg(villin-CD97) mice with increasing 
transgene copy number, designated Tg1, Tg2, and Tg3 (Becker 
et al., 2010). Owing to poor reproduction, Tg3 was eventually lost, 
allowing only an initial intestinal assessment of this line.
Macroscopic inspection of adult animals revealed a significant 
increase in length and weight of the small intestine in Tg2 and Tg3 
compared with wild-type (WT) mice (Figure 2, B and C). Whereas 
WT mice had small intestines with a length of 40.0 ± 0.4 cm and a 
weight of 1.19 ± 0.03 g, the small intestines of Tg2 and Tg3 mice 
were 48.3 ± 0.4 and 53.9 ± 0.8 cm in length and 2.13 ± 0.03 and 
3.32 ± 0.03 g in weight (all p < 0.001), respectively. The megaintes-
tine phenotype correlated with a transgene copy number of 10–15 
in Tg1, 70–80 in Tg2, and ∼400 in Tg3 (Becker et al., 2010). 
Although in Tg2, changes were restricted to the small bowel and 
colon length and weight were unchanged, Tg3 mice also developed 
pattern. Thus dietary transition at the end of the suckling period 
correlates with a change in intestinal growth pattern. Whether this 
change is the result of the dietary transition and/or changes in en-
dogenous growth factors or is determined primarily by a genetic 
program switch during intestinal epithelial suckling-to-weaning tran-
sition and modulated secondarily by diet and/or growth factors is 
under debate (Cummins and Thompson, 2002; Harper et al., 2011; 
Muncan et al., 2011).
The adhesion class of G protein–coupled receptors (adhesion-
GPCRs) comprises seven-span transmembrane (TM7) molecules 
with unusual long extracellular parts containing a juxtamembranous 
GPCR autoproteolysis-inducing domain (Langenhan et al., 2013). 
This domain facilitates cleavage into an extracellular N-terminal 
fragment (NTF) and a TM7/cytoplasmic C-terminal fragment (CTF), 
which remain associated during expression at the cell surface (Lin 
et al., 2004; Arac et al., 2012). The NTF of adhesion-GPCRs can pos-
sess a variety of protein modules mediating cell and matrix interac-
tions (Hamann et al., 1995; Langenhan et al., 2013). Adhesion-
GPCRs are involved in developmental processes, including planar 
cell polarity (Usui et al., 1999), tissue polarity (Langenhan et al., 
2009), neural development (Monk et al., 2009; Boutin et al., 2012), 
angiogenesis (Kuhnert et al., 2010), and cardiogenesis (Waller-Evans 
et al., 2010). How these functions are executed at the molecular 
level is poorly understood, essentially due to uncertainty about the 
role of the hitherto-identified adhesion-GPCR binding partners, the 
cooperation between the NTF and the CTF, and the downstream 
signaling pathways (Langenhan et al., 2013).
CD97 is an adhesion-GPCR expressed by various normal cell 
types, including immune, epithelial, and muscle cells (Eichler et al., 
1994; Hamann et al., 1995; Aust et al., 1997; Steinert et al., 2002). In 
the normal human intestine, CD97 is located in enterocytic cell–cell 
contacts, whereas gastrointestinal carcinomas strongly express 
CD97 in the membrane and the cytoplasm (Steinert et al., 2002; 
Becker et al., 2010). We previously reported that constitutive over-
expression of CD97 in intestinal epithelial cells in transgenic (Tg) 
mice stabilizes membranous nonphosphorylated β-catenin, result-
ing in a strengthening of adherens junctions and an attenuation of 
experimental colitis (Becker et al., 2010).
Unexpectedly, Tg(villin-CD97) mice develop an overt megaintes-
tine phenotype, which we characterize here in detail. We show that 
massive enlargement of the upper intestine appears after birth and 
before weaning, yet with normal microscopic intestinal morphology, 
and coincides with enhanced crypt fission. Our data indicate that 
ectopic CD97 expression provides a unique model for enhanced 
cylindrical growth of the small intestine that we assign to the TM7/
intracellular CTF of the receptor.
RESULTS
CD97 is expressed in crypt cells of the human 
small intestine
Immunohistochemical investigation of the human intestines re-
vealed in normal colon a gradient in CD97 expression along the 
crypt axis, that is, CD97 was more expressed in lateral cell con-
tacts of intestinal epithelial cells near the bottom of the crypt 
(Figure 1A). Similarly, in the small intestine, CD97 was present in 
the crypts, but expression became weaker along the crypt–villus 
axis (Figure 1B).
The intestinal expression pattern of CD97 in the mouse differs 
from that in humans (Veninga et al., 2008). In immunostained sec-
tions, intestinal epithelial cells were nearly CD97 negative, whereas 
cells or extracellular matrix within the lamina propria mucosae ex-
pressed CD97, as in humans (Figure 1, C and D). In addition, in 
FIGURE 1: CD97 is located in lateral cell contacts of crypt cells in 
human CD97 and shows a gradient in expression along the crypt in 
the colon (A) and the crypt–villus axis in the small intestine (B). In crypt 
cells, CD97 is located mainly in lateral cell contacts (arrowheads; scale 
bar, 50 μm). In the murine colon (C) and small intestine (D), CD97 is 
not present in immunostained intestinal epithelial cells (2-wk-old 
mouse; scale bar, 25 μm).
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and width of intestinal epithelial cells and 
thus the number of epithelial cells/villus (data 
not shown); 5) the commitment of multipo-
tential resorptive and secretory precursor 
cells, as can be concluded from mRNA levels 
of intestinal enzymes necessary for the diges-
tion of high-fat-rich milk or solid carbohy-
drate-rich diet (Figure 3D), the number and 
position of Paneth, goblet, and enteroendo-
crine cells (Figure 3E and data not shown); 
and 6) the number and position of bromode-
oxyuridine (BrdU+) and active capase-3+ en-
terocytes (Figure 3F and data not shown) 
along the crypt–villus axis. Thus the increase 
in length and diameter of the small intestine 
in adult Tg2 mice was not associated with 
changes in morphology or cell composition.
Intestinal enlargement in 
Tg(villin-CD97) mice occurs after birth 
and before weaning as an intrinsic trait
Newborn Tg2 mice showed the same length 
and weight of the small intestine as WT ani-
mals. Between weeks 2 and 3 after birth, 
Tg2 mice started to gain in small intestine 
length and weight that continued to in-
crease (Figure 4A) without affecting the total 
body weight (Figure 4B).
Because the enlargement of the small 
intestine during lactation depends on 
growth factors in the milk such as lactofer-
rin (Zhang et al., 2001; Cummins and 
Thompson, 2002; Liao et al., 2012), we 
tested whether these factors caused the 
megaintestine phenotype in Tg(villin-CD97) 
mice. This possibility could be excluded 
because only Tg2 but not WT pups, de-
rived from Tg2 females and WT males, de-
veloped a megaintestine (Figure 4C). 
Moreover, Tg2 pups from WT females and Tg2 males also showed 
a gain in length and weight of the small intestine (data not shown). 
In agreement, no obvious differences in the relative amount of 
major milk proteins, including lactoferrin, were found in Tg2 mice 
(Figure 4D). Finally, we examined whether expression of the lacto-
ferrin receptor is increased in Tg2 mice. We confirmed highest lev-
els of lactoferrin receptor mRNA in the small intestine (Suzuki and 
Lonnerdal, 2004) but found no changes in expression in infant Tg2 
mice (Figure 4E).
During suckling, the epithelium expresses enzymes to digest fat-
rich milk. We found no differences in the expression and time course 
of mRNAs of these enzymes between Tg2 and WT mice (Figure 
3D). Argininosuccinate synthetase 1, necessary for the de novo syn-
thesis of arginine absent in milk, and β-galactosidase, indispens-
able for the absorption of intact milk macromolecules, were ex-
pressed at high levels postnatally and down-regulated toward the 
end of the suckling period. In parallel, sucrase isomaltase and tre-
halase, which are involved in carbohydrate processing and required 
to digest solid diet, were up-regulated during the suckling-to-
weaning transition.
Systemic or local growth factors such as growth hormone (GH), 
insulin-like growth factor 1 (IGF-1), IGF-2, and glucagon-like peptide 
2 (GLP-2) stimulate intestinal growth (Ulshen et al., 1993; Ohneda 
a longer colon (8.50 ± 0.18 cm) compared with WT mice (7.41 ± 
0.15 cm; p < 0.05), suggesting that at very high copy number, 
CD97 overexpression also affects the large bowel. Figure 2A shows 
CD97 Western blot analysis of intestinal lysates, and Figure 2B 
shows pictures taken from the small intestine and the cecum of WT, 
Tg1, Tg2, and CD97 knockout (Ko) mice.
Intestinal enlargement in Tg2 mice involved all three segments 
of the small bowel but was more pronounced in the duodenum and 
jejunum and independent of feces content (Figure 2D). Morpho-
metric analysis revealed an increase in diameter in each segment of 
the small bowel (Figure 2E). Food and water intake at random per 
day was comparable between WT and Tg mice, as was the amount 
of feces (Figure 2F).
CD97 overexpression does not affect intestinal microscopic 
morphology in adult mice
We next analyzed the small intestine of adult Tg2 mice at the micro-
scopic level. We found no differences in 1) the thickness of the tissue 
layers, that is, muscosa, submucosa, and muscularis (data not shown); 
2) the density, shape, length, and width of the villi (Figure 3A) and the 
depth and width of the crypts (Figure 3B); 3) the number of crypts 
feeding a single villus, the number and pattern of villi and crypts per 
area, and the percentage of crypt fissions (Figure 3C); 4) the length 
FIGURE 2: Tg(villin-CD97) mice develop megaintestine. (A) CD97 protein expression in lysates 
of the small intestine of two WT, Tg1, Tg2, and CD97Ko mice analyzed by Western blotting 
using an antibody directed to the CTF of CD97 (Mr, molecular weight marker). (B) Pictures taken 
from freshly prepared small intestine and cecum of several mouse strains show the increase in 
length of the small bowel in Tg2 mice. (C) Length and weight of the small intestine increased in 
adult Tg2 and Tg3 mice (Tg3, n = 6; other strains, n = 16; mean ± SEM; *p < 0.05, ***p <0.001). 
(D) The increase in weight concerned all segments of the small bowel but was more pronounced 
in the duodenum (duo) and jejunum (jeju). Differences were independent of feces content 
(***p < 0.001). (E) Cross-sectional diameter increased in all segments of the small bowel in Tg2 
mice (***p < 0.001). (F) Daily food intake and drinking ad libitum and the quantity of feces were 
comparable between mouse strains (n = 10/strain).
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et al., 1997; Lovshin et al., 2000; Cummins and Thompson, 2002). 
Their circulating levels peak partly in the postnatal period, at which 
intestinal growth is most significant. In infant Tg2 mice, serum levels 
of IGF-1, IGF-2, and GLP-2 were not enhanced (Figure 5A). In line 
with this, mRNA levels of these factors and their receptors (Figure 5, 
B and C) and the percentage and position of the GLP-2+ cells 
(Figure 5D) were not changed in the intestine of infant and adult Tg2 
mice. Moreover, serum GH, measured at fixed time points to ex-
clude effects from diurnal fluctuation (Sinha et al., 1977), did not 
vary between infant and adult Tg2 and WT mice (Figure 5E). We 
conclude that the megaintestine in Tg(villin-CD97) mice develops 
during the suckling period, independent of the availability milk-de-
rived and intrinsic growth factors and digestive enzymes.
Crypt fission and enterocyte proliferation are transiently 
enhanced in infant Tg(villin-CD97) mice
Next we carefully examined various intestinal morphometric param-
eters in infant Tg2 mice. The thickness of the different tissue layers 
and the shape, length, and width of the villi were comparable to 
those of WT animals (Figure 6, A and B). We found an increase, how-
ever, in the depth and width of the crypts in Tg2 mice (Figure 6, C 
and D). Crypt width, determined in the duodenum and jejunum, 
showed a normal distribution in WT mice, whereas in Tg2 mice, the 
mean crypt width was greater, and a notable increase in the number 
of very large crypts was seen (Figure 6E). These enlarged crypts were 
crypts immediately before or during fission (Figure 6F). The percent-
age of crypt fissions was fourfold higher in Tg2 than with WT mice, 
although the number of crypts and the crypt/villus ratio did not vary 
(Figure 6F).
In the small but not the large intestine of infant Tg2 mice, the 
number of proliferating intestinal epithelial cells was increased 2 
h and, markedly, 24 h after BrdU application (Figure 7, A and B). 
Determination of the position of BrdU+ cells along the crypt–vil-
lus axis confirmed this observation (Figure 7C). CD97 overex-
pression increases the crypt zone, which contains highly prolif-
erative cells in the transit from the stem cell region to the villi 
called transit-amplifying cells (Potten, 1998; Crosnier et al., 
2006). In terms of the prospective fate they are not stem cells: all 
their progeny will differentiate and die (Crosnier et al., 2006). Of 
interest, this increase was transient because in adult mice, no 
difference in the number and position of BrdU+ cells between 
WT and Tg2 was seen (Figure 3F).
Intrinsic factors driving differentiation and continuous 
renewal of intestinal epithelium are normally present 
in Tg(villin-CD97) mice
Intestinal enlargement during the first postnatal weeks is accompa-
nied by increased expression of intestinal stem cell (ISC) markers 
(Dehmer et al., 2011). Quantification of mRNA to the ISC markers 
leucine-rich repeat-containing GPCR 5 (Lgr5), olfactomedin 4 
(Olfm4), and telomerase reverse transcriptase (Tert) confirmed, in 
part, their higher expression in infant compared with adult mice but 
did not reveal a difference between Tg2 and WT animals (Figure 8A). 
Moreover, cell fate decisions, shown here exemplarily for the number 
and position of goblet cells, were not altered by CD97 overexpres-
sion in infant and adult Tg2 mice (Figure 8B and data not shown).
The Wnt pathway plays a pivotal role in proliferation and differ-
entiation of intestinal epithelial cells. We previously demonstrated 
stabilization of nonphosphorylated β-catenin in the intestine of 
Tg(villin-CD97) mice that was not translocated to the nucleus (Becker 
et al., 2010). In line with this, mRNA levels of the Wnt target genes 
axin-2, ephrin B3, and CD44 (Figure 8C) and nuclear localization of 
β-catenin in crypts of the small intestine (Figure 8D) were not 
changed in infant and adult Tg2 mice. In conclusion, enterocyte pro-
liferation and crypt fission are transiently enhanced in Tg(villin-CD97) 
mice independent of ISC marker expression, cell fate decision, and 
Wnt pathway activity.
These data were confirmed by microarray analysis in which we 
identified 7074 genes to be expressed in mice jejunum of 2.5-wk-
old mice. A total of 201 transcripts were differentially expressed with 
a fold change of >2 between WT and Tg2 (Supplemental Table S1). 
Of these, 95 showed down- and 106 showed up-regulation in Tg2 
compared with WT mice. Kyoto Encyclopedia of Genes and Ge-
nomes (KEGG) pathway-enrichment analysis revealed that neither 
the Wnt (contains n = 1 of the differentially expressed transcripts) 
nor the Notch (n = 0) or Hedgehog (n = 0) signaling pathway, all in-
volved in epithelial differentiation and continuous renewal (van den 
Brink et al., 2004; Fre et al., 2005; Kim et al., 2005; van Es et al., 
2005; Cervantes et al., 2009; van Dop et al., 2009; Yamada et al., 
2010), were enriched. In the pathway Cell cycle, only one transcript 
was altered. Significant enrichments of differentially expressed 
genes were found in metabolic pathways as Drug metabolism/Me-
tabolism of xenobiotics by cytochrome P450 (n = 8), Retinol me-
tabolism (n = 6), and Fatty acid metabolism (n = 5). These metabolic 
pathways comprised, in part, the same transcripts, for example, for 
alcohol dehydrogenases and glutathione S-transferases, and analy-
sis of differentially expressed genes with a fold change of >3 re-
vealed no significant gene enrichment in any pathway. Thus, in in-
fant Tg2 and WT jejunum, changes in global gene expression were 
small. Whether these alterations indeed result in an additional intes-
tinal enlargement must be shown in future experiments.
Regulation of intestinal growth depends on the C-terminal 
fragment of CD97
Adhesion-GPCRs are two-subunit molecules with an adhesive NTF 
and a signaling CTF. Because evidence suggests that the fragments 
might function as separate entities (Langenhan et al., 2013), we 
studied the contribution of the TM7/intracellular CTF to the me-
gaintestine phenotype. Tg(villin-CD97/two-span transmembrane 
[TM2]) mice were generated that overexpress a CD97 receptor with 
only the first two membrane-spanning helices (Figure 9A). Six inde-
pendent founders were identified (Figure 9B), giving rise to the lines 
TgTM2/1–6. In all lines, intestinal epithelial cells overexpressed 
CD97 (Figure 9C). The relative copy number of the CD97 transgene 
in the genome was calculated. TgTM2/1, 2, and 5 mice had 
integrated a number of CD97 cDNA copies that was equal to or 
higher than the number with the Tg2 strain (Figure 9D). Nonethe-
less, none of the TgTM2 lines developed a megaintestine (Figure 
9E), indicating that the CTF of CD97 was necessary for induction of 
the megaintestine phenotype.
To study the role of CD97-mediated cell adhesion in develop-
ment of the megaintestine, we crossed Tg(villin-CD97) mice with 
mice lacking CD55, a binding partner of CD97 that is present at low 
levels in enterocytes (Koretz et al., 1992; Hamann et al., 1996). Adult 
Tg2 × CD55 Ko mice developed a megaintestine that was indistin-
guishable from the phenotype in Tg2 mice, indicating that CD55 
binding is not required for megaintestine induction (Figure 9F).
DISCUSSION
We report here that ectopic expression of CD97 in intestinal epithe-
lial cells causes a massive enlargement of the small intestine without 
affecting microscopic morphology, multiple enterocytic cell lineage 
decisions, epithelial renewal, and suckling-to-weaning transition. 
The phenotype of the Tg(villin-CD97) mouse is unique compared 
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FIGURE 4: The megaintestine phenotype in Tg(villin-CD97) mice develops postnatally before 
weaning. (A) At the age of 3 wk, Tg2 mice started to gain in length and weight of the small 
intestine (n = 10/strain, mean ± SEM). (B) Body weight of Tg2 was comparable to that of the 
other mice (n = 10/strain). (C) Tg2 females were crossed with WT males. Only Tg2 offspring 
showed gain in weight and length of the small bowel (n = 4 litters with 15–20 pups/strain, 
**p < 0.01). (D) Major milk proteins, such as lactoferrin, albumin, several caseins, and whey acidic 
protein, examined by SDS–PAGE were not different between Tg2, WT, Tg1, and CD97Ko at day 
10 of lactation. (E) The small intestine showed the highest relative expression of lactoferrin 
receptor (LfR) mRNA compared with other tissues (left; normalized to lung). In 3-wk-old Tg2 
mice, LfR mRNA levels in the duodenum and colon were not altered (right; n = 4 mice/strain; 
normalized to WT).
FIGURE 3: Adult Tg(villin-CD97) mice 14 wk of age have a normal intestinal microscopic morphology. (A) Stereo and 
raster electron micrographs reveal no differences in size, shape, and density of the villi in the duodenum of Tg2 mice. 
Luminal views are provided of wet-fixed samples (top; scale bar, 0.5 mm) and dried samples (bottom; scale bar, 0.2 mm). 
Right, morphometric analysis of HE-stained sections (n = 6 mice/strain; mean ± SEM). (B) The depth and width of the 
crypts are unchanged in adult Tg2 mice. Raster electron micrographs (left; scale bar, 0.1 mm) and morphometric analysis 
of HE-stained sections of the duodenum (right; n = 6 mice/strain). (C) The number of crypts that feed one villus and the 
number of crypt fissions are the same in Tg2 mice, as shown here for the duodenum (n = 4 mice/strain). (D) Duodenal 
mRNA levels of intestinal enzymes (Ada, adenosine deaminase; Arg2, arginase 2; Ass1, argininosuccinate synthetase 1; 
Glb1, β-galactosidase; Sis, sucrase isomaltase; Treh, trehalase) in Tg2 and WT mice at early life and adulthood are not 
different. RSP29 normalized log2 x-fold mRNA levels of several mouse groups compared with that of adult WT mice, 
which were set to 1 (n = 3 mice/group, mean ± SEM). (E) The number and position of Paneth cells, stained for lysozyme, 
was comparable in all segments of the small bowel of Tg2 mice (scale bar, 20 μm). (F) Determination of the position of 
BrdU+ cells along the crypt–villus axis of the duodenum at 2 and 24 h after BrdU incorporation revealed no changes in 
Tg2 mice (n = 6/strain; on average, four crypt–villus structures per mouse were counted).
associated with an increase in the crypt tran-
sit-amplifying zone, and thus crypt size and 
fission during this period. Owing to these 
characteristics, the Tg(villin-CD97) mouse 
provides a specific in vivo model for cylindri-
cal intestinal growth, the dominant growth 
pattern in breast-fed infants.
Short-bowel resection in mice, in which 
50% of the small intestine is surgically re-
moved, induces an increase of the absorp-
tive intestinal surface, primarily due to lumi-
nal mucosal growth (Helmrath et al., 1996). 
It resembles regeneration in the small bowel 
syndrome seen in patients after extensive 
resection of the small intestine (Helmrath 
et al., 1996; Thompson et al., 2012). In mice 
and patients, the intestinal remnants in-
crease nutrient absorption through struc-
tural changes, such as villous cell hyperpla-
sia and dilation, and through functional 
mechanisms, such as increased mucosal en-
zyme activity and reduction of intestinal 
transit time (Thompson et al., 2012). We ob-
served none of these changes in Tg(villin-
CD97) mice, fairly excluding contribution of 
luminal growth to the megaintestine pheno-
type. The Tg(villin-CD97) mice thus could 
be useful to understand and potentially acti-
vate cylindrical growth in patients with con-
genital or acquired small bowel syndrome.
How is CD97 involved in intestinal size 
control? The transient increase in enterocytic 
proliferation suggests a mitogenic effect of 
CD97. According to in silico simulations us-
ing an individual cell-based model of the in-
testinal crypt (Buske et al., 2011), such an 
effect is sufficient to increase crypt size, 
which inevitably results in enhanced crypt 
fission. Nevertheless, this effect is surprising 
because 1) gene expression analysis re-
vealed no alterations in the Cell cycle pathway and only moderate 
changes in global gene activity and 2) CD97 overexpression (Galle 
et al., 2006) and siRNA knockdown (www.mitocheck.org) did not al-
ter proliferation in tumor cells. So the questions remain about how 
this effect is induced by CD97 and why is it confined to the suckling 
period.
with existing megaintestine models, in which alteration of intestinal 
size is often accompanied by dramatic morphological changes 
(Ohneda et al., 1997; Lovshin et al., 2000; Zhang et al., 2001; Lelievre 
et al., 2007; Tamura et al., 2008; Cervantes et al., 2009; Langlois 
et al., 2009; Lussier et al., 2010; Yamada et al., 2010). Acquisition of 
the megaintestine occurred after birth and before weaning and was 
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FIGURE 5: No change of several growth factors and their receptors in 
Tg2 mice. (A) Circulating IGF-1, IGF-2, and GLP-2 levels were 
comparable in 3-wk-old mice of the various strains (n = 10/strain, mean 
± SEM). (B, C) Duodenal mRNA levels of IGF-1, IGF-2, their receptors 
(IGF-1/2R), and the GLP2 receptor (GLP-2R) were not different in Tg2 
and WT mice at early life and adulthood. RSP29 normalized log2 x-fold 
mRNA levels of several mouse groups compared with that of adult WT 
mice, which were set to 1 (n = 3 mice/group, mean ± SEM). 
(D) Staining for GLP-2 revealed the same number and position of 
these rare enteroendocrine cells in the duodenum of 3-wk-old WT 
and Tg2 mice (scale bar, top, 20 μm; bottom, 50 μm). (E) Circulating 
GH determined at fixed time points (7.00–7.30 and 9.00–9.30 am for 
low and high GH levels, respectively) did not vary between infant and 
adult WT and Tg2 mice (n = 10/strain; mean ± SEM).
We first hypothesized that CD97 induces the megaintestine by 
regulating molecules known to change growth behavior and deter-
mine the size of the small intestine, such as 1) transiently available 
trophic or endogenous growth factors and/or their receptors, 
2) modulators of ISCs, and 3) regulators of the Wnt pathway.
CD97 overexpression may regulate a temporally available growth 1. 
factor in the milk, such as lactoferrin, or its receptor (Liao et al., 
2012). We found that suckling Tg2 but not WT pups developed a 
megaintestine phenotype independent of the genotype of the 
mother, thus excluding this possibility. Moreover, we showed that 
lactoferrin receptor mRNA levels were unchanged in Tg2 mice. 
Next to milk constituents, circulating and intestinal endogenous 
growth factors promote intestinal enlargement. Enhanced avail-
ability of these factors causes significant alterations in intestinal 
microscopic morphology, suggesting promotion of primarily in-
testinal luminal growth (Ulshen et al., 1993; Ohneda et al., 1997; 
Lovshin et al., 2000; Cummins and Thompson, 2002; Lelievre 
et al., 2007). We found no changes in several growth factors and 
their receptors in Tg2 mice. Nevertheless, we cannot exclude at 
this point that CD97 regulates the binding or signaling of a recep-
tor for a (milk) growth factor in the small intestine during breast-
feeding.
ISCs residing at the base of the crypts, quiescent in the 4+ posi-2.  
tion, directly above the Paneth cells, or as crypt base columnar 
cells scattered between them, are responsible for the differentia-
tion and continuous renewal of intestinal epithelial cells (Umar, 
2010). This activity persists throughout life at a stable level, which 
contrasts notably with intestinal cylindrical growth that peaks 
during infancy and declines rapidly thereafter. Whether the 
recently described increase in ISC marker expression during 
intestinal growth (Dehmer et al., 2011) suggests that ISCs drive 
intestinal cylindrical growth remains to be shown. Although we 
found an increase in BrdU incorporation in crypt cells and in crypt 
fission in infant Tg2 mice, mRNA expression of the ISC markers 
Lgr5, Tert, and Olfm4 was not enhanced.
Activation of the Wnt cascade such as through Wnt5a/Ror2 or 3.  
R-spondin regulates morphogenesis of the small intestine prena-
tally and postnatally (Kim et al., 2005; Cervantes et al., 2009; 
Yamada et al., 2010). In Tg(villin-CD97) mice, the gain in intesti-
nal size was not associated with increased Wnt signaling. The 
percentage of crypt cells with nuclear localization of β-catenin 
and the mRNA levels of Wnt target genes were not increased in 
infant and adult Tg2 mice, confirming our previous finding that 
CD97 overexpression stabilizes nonphosphorylated membrane-
bound and cytosolic β-catenin but does not cause its transloca-
tion to the nucleus (Becker et al., 2010). This finding was con-
firmed additionally by genome-wide expression analysis. 
Regulation of the Wnt, Notch, and Hedgehog pathways, all in-
volved in epithelial differentiation and continuous renewal (van 
den Brink et al., 2004; Fre et al., 2005; Kim et al., 2005; van Es 
et al., 2005; Cervantes et al., 2009; van Dop et al., 2009; Yamada 
et al., 2010), by CD97 overexpression seems to be unlikely.
Ruling out several growth factors, stem cell numbers, and Wnt 
activity as the origin of the transient CD97-induced mitogenic effect, 
we are investigating two other scenarios. First, proteins located in 
lateral epithelial cell junctions possess functions related to control-
ling intestinal size after birth. The best evidence comes from claudin-
15–deficient and, to a lesser extent, claudin-2–deficient mice, which 
grow normally with an enlarged upper small intestine (Tamura et al., 
2008, 2011). In contrast to our transgenic mice, the megaintestine in 
these mice developed after weaning and correlated with massive 
morphological changes such as are typical for luminal intestinal 
growth (Tamura et al., 2008). In the normal human intestine and in 
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FIGURE 6: The percentage of crypt fission is increased In 3-wk-old infant Tg(villin-CD97) mice. (A) In Tg2 and WT mice, 
the microscopic morphology of the small intestine was comparable, as seen in HE cross-sections (left) and in stereo 
micrographs of the duodenum (right; scale bar, 0.2 mm). (B, C) The depth and width of the crypts was increased, 
whereas the length and width of the villi was unchanged in the duodenum of 3-wk-old Tg2 mice (6 mice/strain; mean ± 
SEM; **p < 0.01). (D) In infant Tg2 mice, enlarged crypts were seen. The detail shows how depth and width of a crypt 
were measured (hematoxylin; scale bar, 25 μm). (E) The crypt width (duodenum, n = 150; ileum, n = 125 crypts/strain 
counted) was normally distributed in WT but not Tg2 mice. In Tg2 mice, the width of all crypts and especially of 
enlarged crypts in fission was increased. (F) The number of crypts in fission was increased in Tg2 mice, whereas the 
number of crypts/area was unchanged compared with WT (n = 6 mice/strain; *p < 0.05). Analysis of serial HE-stained villi 
and crypt cross-sections revealed no changes in the number of crypts that feed one villus (n = 5 mice/strain). Two 
fissioning crypts in the duodenum of a Tg2 mouse are shown as examples in the micrograph. Nuclei were stained for 
BrdU incorporation for 2 h and counterstained with hematoxylin.
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Tg(villin-CD97) mice CD97 is located in adherens junctions, which 
are strengthened by CD97 (Becker et al., 2010). Thus intestinal over-
expression of CD97 modulates the regulation of adherens junctions 
and intestinal growth simultaneously, yet a causative relationship, if 
one exists, remains to be established.
Second, there is increasing evidence that developmental and 
differentiation processes are controlled by chromatin modifiers as 
shown recently for ISCs (Benoit et al., 2012). Crypts contain two 
physically distinct proliferative compartments—the stem cell zone 
and the transit-amplifying zone, which is located in the middle of the 
crypt containing the fast-growing and differentiating transit cells 
(Potten, 1998; Crosnier et al., 2006). The increase in the BrdU+ crypt 
zone and thus crypt size in suckling Tg(villin-CD97) mice suggests 
that CD97 overexpression increases this transit-amplifying zone per-
haps by interfering with chromatin modifiers such as the polycomb 
repressive complex 2 (Benoit et al., 2012). Changes in chromatin 
modifier activity would not necessarily change microscopic mor-
phology as in the relation between the absorptive and the secretory 
cell lineages or villus size. However, how an increase in the transit-
amplifying zone may result in a cylindrical intestinal enlargement 
remains unexplained.
Our data provide new insights into signaling of adhesion-GPCRs 
(Langenhan et al., 2013). Typically for these receptors, CD97 consists 
of an extracellular NTF and a TM7/cytoplasmic CTF (Hamann et al., 
1995; Gray et al., 1996). We recently described a role of CD97 in 
susceptibility to experimental arthritis and granulopoiesis, which 
correspond to very similar phenotypes in mice lacking CD55, 
suggesting a role of the CD97–CD55 interaction in leukocyte 
adherence (Hoek et al., 2010; Veninga et al., 2011). In the present 
study we did not find this phenocopy. CD55 Ko mice have a normal 
intestine, that is, development of the megaintestine in Tg(villin-
CD97) mice does not require the presence of the ligand CD55. In 
marked contrast, intestinal enlargement requires the presence of 
7TM/intracellular CTF. Our study strengthens the hypothesis that the 
NTF and CTF of adhesion-GPCRs might execute separate functions, 
related to cell adhesion and signaling (Langenhan et al., 2013).
In summary, the adhesion-GPCR CD97 can markedly enhance 
intestinal enlargement within the limited time period of predomi-
nant cylindrical growth, correlating with the suckling period. It should 
be noted that intestinal cylindrical growth, that is, a gain of length 
and diameter and thus the area of the intestine, requires a parallel 
expansion of the deeper intestinal layers, such as the submucosa, 
muscularis, and serosa. CD97 overexpression in the intestinal epi-
thelium is sufficient to induce an enlargement of all intestinal layers, 
without obvious morphological changes. Thus Tg(villin-CD97) mice 
provide a unique model with which to study and understand mecha-
nisms and molecules underlying cylindrical growth of the small intes-




This research complied with the ethics guidelines of the University of 
Leipzig and the Academic Medical Center, Amsterdam. For the gen-
eration of transgenic mice and for animal experiments, we obtained 
ethics approval from the Landesdirektion Leipzig (TVV16/11) and the 
Academic Medical Center, Amsterdam (DSK10044-175). Human in-
testinal samples were studied with approval from the Ethics Commit-
tee of the Medical Faculty of the University of Leipzig (028/2000, 
111/2009). Written consent was obtained from all study participants.
Transgenic mice
The generation of Tg(villin-CD97) mice, expressing full-length mouse 
CD97(EGF1,2,3,4) under control of the villin promoter, has been de-
scribed (Becker et al., 2010). Tg(villin-CD97/TM2) mice, expressing 
CD97(EGF1,2,3,4) with only the first two of the seven transmembrane 
FIGURE 7: Increased intestinal proliferation in 3-wk-old Tg(villin-CD97) mice. (A, B) The length of the proliferating zone 
was increased in all segments of the small intestine but not the colon of Tg2 mice (n = 6/strain; mean ± SEM; *p < 0.05, 
***p < 0.001) at 2 and 24 h after BrdU incorporation. Shown here is the duodenum. (C) Determination of the position of 
BrdU+ cells along the crypt–villus axis of the duodenum 2 and 24 h after BrdU incorporation (n = 6/strain; on average, 
four crypt–villus structures/mouse were counted).
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FIGURE 8: CD97 does not alter cell fate decision, β-catenin localization, and mRNA levels of 
Wnt target genes. (A) mRNA levels of ISC markers in Tg2 and WT mice at early life and 
adulthood were not different. Olfm4 and Lgr5 as markers of crypt base columnar cells and 
Tert as a marker for position 4+ ISC were quantified by real-time PCR. RSP29 normalized log2 
x-fold mRNA levels of the ISC marker gene of several mouse groups compared with that of 
adult WT mice, which were set to 1 (n = 3 mice/group, mean ± SEM). (B) Alcian blue/neutral 
red staining revealed the same number and position of goblet cells in the various parts of the 
small intestine of infant 2.5-wk-old Tg2 and WT mice (scale bar, 0.15 mm). (C) mRNA levels of 
Wnt target genes known to be up-regulated by nuclear β-catenin were quantified by 
real-time PCR in adult mice. RSP29-normalized log2 x-fold mRNA levels of ephrin B3, axin-2, 
and CD44 compared with WT mice (n = 3 mice/group; mean ± SEM). (D) Intracellular 
localization of β-catenin in infant 2.5-wk-old Tg2 and WT mice was examined by 
immunohistology (scale bar, 10 μm). Only a few crypt epithelial cells with faint nuclear 
β-catenin staining, most likely Paneth cells, were seen in both strains (arrowheads). Inserts 
show costaining for β-catenin and HE.
helices and without the intracellular C-ter-
minus, were generated by a comparable 
approach. The expression construct was 
created by placing a 9-kb regulatory region 
of the villin gene upstream of a 
CD97(EGF1,2,3,4) cDNA, truncated behind 
Val-583. The CD97(EGF1,2,3,4/TM2) cDNA 
was amplified from a pcDNA3.1/Zeo(+)-
mCD97(EGF1,2,3,4) construct (Hamann 
et al., 2000), using the primer pair 
5′-ccgcgtacggccaccatga gga gcgtc-3′/5′-
tgtcacgcgtcacg ccg acca ggaatatgat-3′, and 
subcloned via BsiWI and MluI into a pBS-
KS-Villin-MES-SV40-polyA plasmid (Pinto 
et al., 1999), kindly provided by S. Robine 
(Institute Curie, Paris, France). Tg(villin-
CD97/TM2) mice were generated by pro-
nuclear microinjection as described (Becker 
et al., 2010). Founders were screened by 
amplification of the transgene using prim-
ers 5′-tgccttctcc tctaggctcgt-3′/5′-gtcctgca-
catggtactgag-3′, generating a 1500–base 
pair PCR product. To establish Tg(villin-
CD97/TM2) lines, founders were mated to 
C57BL/6J WT mice (Charles River, Sulzfeld, 
Germany). Six transgenic lines were ob-
tained. The relative copy number of the in-
tegrated CD97 cDNA in these lines was 
calculated by real-time PCR.
CD97 Ko mice were generated before 
(Veninga et al., 2008). Tg(villin-CD97) × 
CD55 Ko mice were derived by crossing 
Tg2 with CD55 Ko mice (Lin et al., 2001), 
kindly provided by M. E. Medof (Case 
Western Reserve University, Cleveland, OH). 
All mice were crossed back on a C57BL/6J 
background, and WT littermates were used 
as controls. Mice were housed under spe-
cific pathogen-free conditions.
Food and water intake and defecation
Food and water intake and defecation were 
measured daily for 4 d in metabolic cages 
(Ehret, Emmendingen, Germany). Food in-
take was determined by weighing the metal 
cage top, including the food. Deionized 
water was available from a 50-ml bottle with 
0.2-ml gradations. Feces was collected daily 
and weighed. Body weight was measured 
at the beginning and end of the 4-d test.
Milk proteins
Milk was collected at midlactation 10 d after 
birth. Dams separated from their pups 2 h 
before were injected with 0.2 U of synthetic 
oxytocin (Hexal, Holzkirchen, Germany) and 
then anesthetized. Approximately 70 μl of 
milk was collected. Milk was diluted 1:3 with 
Aqua Dest, skimmed by centrifugation 
(4000 × g, 15 min), and separated by SDS–
PAGE. Milk proteins were visualized by 
Coomassie blue staining.
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mined using enzyme-linked immunosorbent 
assay (Kamiya Biomedical Company, Seattle, 
WA, and Millipore, Schwalbach, Germany). 
Based on a diurnal profile of GH generated 
for 2- to 4-wk-old WT mice, daily measure-
ments of low and high GH levels were per-
formed in serum collected at 7:00–7:30 and 
9:00–9:30 am, respectively.
Intestinal morphology
After scarification, the entire small intestine 
and the colon were weighed. The length of 
the small intestine was measured under 
uniform tension. The following segments 
were dissected: duodenum from the pylo-
rus to the ligament of Treitz, proximal jeju-
num (first third of the intestine after the 
ligament of Treitz), and distal ileum (last 
third of the intestine up to the ileocecal 
valve). Each segment was weighed with 
and without feces. The diameter of the 
segments, the thickness of each intestinal 
layer, the length and width of the villi, and 
the depth and width of the crypts were 
measured in hematoxylin-eosin (HE)–
stained sections under a light microscope 
using AxioVision program 4.8 (Carl Zeiss, 
Jena, Germany). The ratio of the number of 
crypts and villi per unit area was calculated 
in serial HE-stained villus and crypt cross-
sections. The number of crypts and the 
percentage of crypt fissions were deter-
mined in longitudinal sections at 5 × 300–
μm length of each intestinal segment. 
Paneth, enteroendocrine, and goblet cells 
were examined by immunostaining with 
polyclonal antibodies for lysozyme, chro-
mogranin A (Dako, Hamburg, Germany), 
and GLP-2 (Santa Cruz Biotechnology, 
Heidelberg, Germany) and by Alcian blue/
neutral red staining, respectively.
Pictures of the intestinal luminal surface 
were obtained from cleaned bowel seg-
ments fixed in 2.5% glutardialdehyde/phos-
phate-buffered saline (PBS) for 24 h, using a 
stereo light microscope (Stemi 2000; Carl 
Zeiss). Afterward, specimens were cut, de-
hydrated, dried in a critical-point apparatus 
(Pelco CPD2; Ted Pella, Redding, CA), and 
examined with a scanning electron micro-
scope (Phenom G2Pro; Phenom-World, 
Eindhoven, Netherlands).
Proliferation and apoptosis
We injected 2 mg/ml BrdU (Sigma-Aldrich, 
Munich, Germany)/PBS intraperitoneally (50 
mg/kg body weight). Mice were killed 2 and 
24 h after injection. In 5-μm paraffin sections, 
proliferating or apoptotic cells were de-
tected by staining with the BrdU In-situ Detection Kit II (BD Biosci-
ences, Heidelberg, Germany) or by staining active caspase-3 with an 
antibody recognizing its p17 subunit (R&D Systems, Wiesbaden, 
FIGURE 9: Tg(villin-CD97/TM2) mice do not develop a megaintestine. (A) Schematic 
representation of the pBS-KS-villin-CD97 construct, showing the villin promoter (hatched box), 
the mCD97 cDNA containing EGF-like domains 1–4, and the SV40 polyadenylation sequence 
(dotted box). (B) PCR of gDNA confirmed integration of the CD97 transgene in six founders. 
(C) CD97 immunostaining of colonic tissue of WT, Tg2, TgTM2/2, and TgTM2/6 mice revealed 
that in WT colon only cells of the lamina propria mucosae were stained, whereas in transgenic 
mice the enterocytes were strongly CD97+. Flow cytometry revealed expression of truncated 
CD97 at the surface of enterocytes in TgTM2 mice. (D) The integrated relative copy number of 
the CD97 transgene was measured by real-time PCR (normalized to Tg1). TgTM2/1, 2, and 5 
integrated a CD97 cDNA copy number greater than or equal to that of the Tg2 mice. (E) Adult 
14-wk-old TgTM2 mice did not develop a megaintestine. Shown here is the weight of the small 
intestine (TgTM2/1 and 4, n = 2; all other lines, n > 5 mice; mean ± SEM). Tg2 but not TgTM2 
mice showed lengthening of the small intestine (right). (F) Tg2 was crossed to CD55 Ko mice. 
Adult 12-wk-old Tg2 × CD55 Ko mice developed a megaintestine phenotype (n > 5 mice/strain).
Serum levels of growth factors
IGF-1 and -2 were measured by radioimmunoassay by L. Pridzun 
(Mediagnost, Reutlingen, Germany). GLP-2 and GH were deter-
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Germany) overnight, followed by detection with the Vectastain Elite 
ABC Kit (Vector Laboratories, Burlingame, CA).
Gene expression
Relative gene expression levels were measured by real-time PCR 
using ABsolute qPCR Sybr Green Mix (Abgene, Epsom, United 
Kingdom) on a Rotor Gene 3000 thermal cycler (Qiagen, Hilden, 
Germany) with the Ct method (Pfaffl, 2001). Expression of specific 
genes was normalized to RPS29 (de Jonge et al., 2007) as endoge-
nous control, using the primers (forward/reverse) 5′-tgaaggcaa-
gatgggtcac-3′/5′-gcacatgttcagcccgtatt-3′. Growth factors and their 
receptors were amplified using the primer pairs lactoferrin receptor 
5′-caggtggggcaattctttcttttc-3′/5′-agttgtgcagggggcttttgtt-3′, IGF-1 
5′-tcatgtcgtcttcacacctcttct-3′/5′-ccacacacgaactgaagagcat-3′, IGF-1 
receptor 5′-gtgggggctcgtgtttctc-3′/5′-gatcaccgtgcagtttc-3′, IGF-2 
5′-acacttcgatttgaaccacattc-3′/5′-gagagctcaaaccatgcaaact-3′, IGF-2 
receptor 5′-gggaagctgttgactccaaaa-3′/5′-gcagcccatagtggtgttgaa-3′, 
and GLP-2 receptor 5′-ccttccccatgctgtttgttattc-3′/5′-agcggcccca-




tcacatc-3′. Wnt target genes were amplified with the primer 
pairs axin-2 5′-caggagcctcacccttcg-3′/5′-acgccgaggtgcttgccc-3′, 
ephrin B3 5′-aacagcttcccctgattgtg-3′/5′-gacccataatggaagcctca-3′, 
and CD44 5′-ggcagaagaaaaagctggtg-3′/5′-acaccccaatcttcatgtc-3′. 
Sucrase isomaltase, trehalase, adenosine deaminase, arginase 2, 
argininosuccinate synthetase 1, and β-galactosidase were amplified 
as described (Muncan et al., 2011).
In addition, gene expression was quantified in the jejunum of 
2.5-wk-old mice with the MouseRef-8 v2.0 Expression BeadChip 
(Illumina, San Diego, CA) comprising 25,697 features. A single array 
was used to measure RNA of two WT and two Tg2 mice with two 
biological replicates each (n = 8 samples in total). Array processing 
was performed using the recommendations of the manufacturer. 
Data were preprocessed on the basis of the nonnormalized, 
not–background-corrected outputs of GenomeStudio (Illumina). 
Transcripts were analyzed if detected in at least four samples with a 
detection p value of 0 and if the signal-to-noise ratio was ≥2. Tran-
scripts were quantile normalized and log 2 transformed. In the sta-
tistical analysis, gene expressions of biological replicates were aver-
aged. Expressions were compared between WT and Tg2 mice by 
calculating t tests and fold changes. Pathway-enrichment analysis 
was performed using DAVID (Huang et al., 2009a,b).
CD97 expression
Quantification of CD97 at the surface of isolated intestinal epithelial 
cells, staining of CD97 in cryostat sections, and Western blotting 
using an antibody directed to the C-terminus of CD97 were per-
formed as described (Veninga et al., 2008; Becker et al., 2010). For 
immunostaining of paraffin-embedded human tissues, 5-μm sec-
tions were rehydrated. Endogenous peroxidase was blocked with 
1.0% H2O2/96% ethanol between the steps absolutely and 96% 
ethanol for 5 min. After antigen retrieval with citrate buffer, pH 6.0, 
the sections were incubated with a rabbit polyclonal antibody to 
CD97 (Sigma-Aldrich) for 30 min. Binding was detected with a bio-
tin-labeled goat anti-rabbit secondary antibody for 30 min, followed 
by Vectastain Elite ABC Kit.
Statistical analysis
Statistical analysis was performed using the Student’s t test or 
Mann–Whitney test; p < 0.05 was regarded as significant.
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